- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
-
- 长期趋势：
已有56家主力机构披露2024-12-31报告期持股数据，持仓量总计9812.68万股，占流通A股17.44%
- 波段诊断：
-
技术面诊股
诊断结果：4.0技术面打败了68%的股票
技术面评分前10的股票
近期的平均成本为13.22元。
平均成本
近期的平均成本为13.22元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"13.22","date":1752135712,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势接近大盘，接近行业平均水平。
[{"date":"2025.07.11","stock":"1.07","trade":null,"ind":"0.61"},{"date":"2025.07.10","stock":"-0.08","trade":null,"ind":"0.47"},{"date":"2025.07.09","stock":"0.31","trade":null,"ind":"-0.06"},{"date":"2025.07.08","stock":"0.15","trade":null,"ind":"1.46"},{"date":"2025.07.07","stock":"0.08","trade":null,"ind":"-0.70"},{"date":"2025.07.04","stock":"-0.83","trade":null,"ind":"-0.25"},{"date":"2025.07.03","stock":"-0.23","trade":null,"ind":"1.17"},{"date":"2025.07.02","stock":"-0.45","trade":null,"ind":"-0.61"},{"date":"2025.07.01","stock":"-0.15","trade":null,"ind":"0.11"},{"date":"2025.06.30","stock":"3.91","trade":null,"ind":"0.83"},{"date":"2025.06.27","stock":"-0.16","trade":null,"ind":"0.34"},{"date":"2025.06.26","stock":"-0.93","trade":null,"ind":"-0.48"},{"date":"2025.06.25","stock":"-0.15","trade":null,"ind":"1.72"},{"date":"2025.06.24","stock":"0.15","trade":null,"ind":"1.68"},{"date":"2025.06.23","stock":"1.25","trade":null,"ind":"0.43"},{"date":"2025.06.20","stock":"2.57","trade":null,"ind":"-0.47"},{"date":"2025.06.19","stock":"-3.04","trade":null,"ind":"-1.21"},{"date":"2025.06.18","stock":"-2.06","trade":null,"ind":"0.24"},{"date":"2025.06.17","stock":"8.26","trade":null,"ind":"-0.12"},{"date":"2025.06.16","stock":"0.83","trade":null,"ind":"0.41"},{"date":"2025.06.13","stock":"-2.44","trade":null,"ind":"-1.10"}]
东富龙,深证成指,医疗器械指数
压力支撑
该股压力位为13.16元，支撑位为13.01元。
[{"text":"\u538b\u529b\u4f4d","value":"13.16","date":1752163200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"13.01","date":1752163200,"color":"0x0b52a1"}]
多空趋势
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.8资金面打败了46%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：07月11日 20:34
| 机构今日流向(万元) | -313.28 | 机构5日流向(万元) | -2624.78 |
| 机构10日流向(万元) | -3672.84 | 机构20日流向(万元) | -9179.08 |
机构持仓
2024-12-31 与 2024-06-30 相比，主力机构持仓量减少1909.45万股，其中基金净增仓5家，主力净减仓3家，暂未发现中长期投资价值。
截止2024-12-31，共56家主力机构（基金50家，一般法人6家），持仓量总计9812.68万股，占流通A股17.44%
其中，基金持仓与2024-06-30相比：
增仓：16家 ，增持 315.68万股
减仓：11家 ，减持 164.44万股
新出现在主力名单中：15家 ，持有99.07万股
从主力名单中消失：18家 ，原持有1611.19万股
其中，基金持仓与2024-06-30相比：
增仓：16家 ，增持 315.68万股
减仓：11家 ，减持 164.44万股
新出现在主力名单中：15家 ，持有99.07万股
从主力名单中消失：18家 ，原持有1611.19万股
消息面诊股
诊断结果：5.6消息面打败了26%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 东富龙：2025年度，公司全员上下在各自岗位积极落
2025-07-11 - 东富龙：7月10日获融资买入1327.14万元
2025-07-11 - 东富龙：7月9日获融资买入1265.08万元，占当
2025-07-10 - 分体式低温样本存储系统的创新与应用
2025-07-09 - 东富龙：7月8日获融资买入736.62万元，占当日
2025-07-09 - 东富龙：再融资募投项目正常开展中，并按照计划稳步推
2025-07-08 - 东富龙：7月7日获融资买入1055.41万元，占当
2025-07-08 - HEK293培养基高质量批量化连续交付--树立生物
2025-07-07 - 喜报！东富龙连续三年荣登中国医药工业百强企业榜
2025-07-07 - 东富龙：7月4日获融资买入974.51万元
2025-07-07
消息列表
| 一般消息 | 募资投向 | 2025-07-04 | |
| 一般消息 | 股东大会 | 年度股东大会 | 2025-04-25 |
| 利好 | 分红转增 | 10派0.76元(含税) | 2025-04-25 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-15 |
| 重大利空 | 业绩预告 | 业绩大幅下降 | 2025-01-24 |
| 一般消息 | 分红转增 | 不分配不转增 | 2024-08-30 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 1条 | 1条 | 0条 |
行业面诊股
诊断结果：3.5行业面打败了51%的股票
医疗器械行业最新资金流向
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
[{"date":"2025.07.11","price":"0.61","value":null},{"date":"2025.07.10","price":"0.47","value":null},{"date":"2025.07.09","price":"-0.06","value":null},{"date":"2025.07.08","price":"1.46","value":null},{"date":"2025.07.07","price":"-0.70","value":null},{"date":"2025.07.04","price":"-0.25","value":null},{"date":"2025.07.03","price":"1.17","value":null},{"date":"2025.07.02","price":"-0.61","value":null},{"date":"2025.07.01","price":"0.11","value":null},{"date":"2025.06.30","price":"0.83","value":null},{"date":"2025.06.27","price":"0.34","value":null},{"date":"2025.06.26","price":"-0.48","value":null},{"date":"2025.06.25","price":"1.72","value":null},{"date":"2025.06.24","price":"1.68","value":null},{"date":"2025.06.23","price":"0.43","value":null},{"date":"2025.06.20","price":"-0.47","value":null},{"date":"2025.06.19","price":"-1.21","value":null},{"date":"2025.06.18","price":"0.24","value":null},{"date":"2025.06.17","price":"-0.12","value":null},{"date":"2025.06.16","price":"0.41","value":null},{"date":"2025.06.13","price":"-1.10","value":"-357279036.44"}]
深证成指,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | ST凯利 | 33.55% | 19.18% | 5.4分 |
| 2 | 热景生物 | 25.19% | -4.01% | 4.4分 |
| 3 | 宝莱特 | 24.30% | 12.91% | 4.5分 |
| 4 | 华强科技 | 23.85% | -1.39% | 3.8分 |
| 5 | 浩欧博 | 23.69% | 22.72% | 5.4分 |
| 6 | 天臣医疗 | 21.84% | 9.20% | 5.4分 |
| 8 | 阳普医疗 | 20.40% | -2.50% | 4.5分 |
| 10 | 英科医疗 | 17.05% | 4.61% | 4.9分 |
| 12 | 福瑞股份 | 15.60% | 20.83% | 5.2分 |
| 14 | 蓝帆医疗 | 13.30% | 5.25% | 5.4分 |
| 16 | 春立医疗 | 12.96% | 0.11% | 5.0分 |
| 18 | 正川股份 | 12.37% | 8.26% | 4.3分 |
| 20 | 博拓生物 | 11.39% | -6.00% | 4.3分 |
| 22 | 港通医疗 | 10.61% | 6.22% | 4.3分 |
| 24 | 睿昂基因 | 9.65% | -2.23% | 4.6分 |
| 26 | 乐心医疗 | 9.55% | 0.58% | 4.5分 |
| 28 | 凯普生物 | 9.46% | 4.07% | 4.2分 |
| 30 | 硕世生物 | 8.83% | 1.57% | 4.3分 |
| 32 | 济民健康 | 8.51% | 1.35% | 4.2分 |
| 34 | 迈普医学 | 8.25% | -4.04% | 4.3分 |
| 36 | 达安基因 | 7.95% | 0.95% | 4.6分 |
| 38 | 康泰医学 | 7.25% | 2.96% | 4.2分 |
| 40 | 透景生命 | 6.92% | 1.41% | 4.1分 |
| 42 | 健帆生物 | 6.81% | -2.63% | 3.9分 |
| 44 | 尚荣医疗 | 6.74% | 1.80% | 4.8分 |
| 46 | 东方海洋 | 6.37% | -1.05% | 3.9分 |
| 48 | 华兰股份 | 6.35% | -0.70% | 3.8分 |
| 50 | 赛科希德 | 6.16% | 1.88% | 4.6分 |
| 52 | 天智航 | 5.97% | 0.35% | 4.3分 |
| 54 | 南微医学 | 5.93% | -0.45% | 4.8分 |
| 56 | 迈克生物 | 5.84% | 3.61% | 4.2分 |
| 58 | 爱迪特 | 5.56% | 1.04% | 4.3分 |
| 60 | 祥生医疗 | 5.37% | 2.86% | 4.8分 |
| 62 | 九强生物 | 5.06% | 1.80% | 4.2分 |
| 64 | 三友医疗 | 4.65% | 3.56% | 4.6分 |
| 66 | 安必平 | 4.55% | 1.13% | 4.2分 |
| 68 | 山东药玻 | 4.51% | 1.46% | 4.9分 |
| 70 | 理邦仪器 | 4.42% | 0.08% | 4.6分 |
| 72 | 爱威科技 | 4.21% | 1.77% | 4.6分 |
| 74 | 欧普康视 | 4.12% | 2.22% | 4.4分 |
| 76 | 拱东医疗 | 3.84% | -6.08% | 4.6分 |
| 78 | 戴维医疗 | 3.58% | -0.23% | 4.3分 |
| 80 | 易瑞生物 | 3.44% | 1.80% | 4.0分 |
| 82 | 亚辉龙 | 3.27% | 1.37% | 4.6分 |
| 84 | 山外山 | 3.12% | 2.82% | 5.0分 |
| 86 | 圣湘生物 | 2.58% | 2.02% | 4.7分 |
| 88 | 万孚生物 | 2.31% | 1.40% | 4.0分 |
| 90 | 海尔生物 | 1.91% | 2.98% | 5.1分 |
| 92 | 新华医疗 | 1.73% | 1.73% | 4.7分 |
| 94 | 基蛋生物 | 1.61% | 1.49% | 4.7分 |
| 96 | 九安医疗 | 1.30% | 0.33% | 4.5分 |
| 98 | 超研股份 | 1.04% | 1.78% | 4.6分 |
| 100 | 英诺特 | 0.99% | 1.46% | 3.9分 |
| 102 | 奕瑞科技 | 0.56% | 4.36% | 4.5分 |
| 104 | 康众医疗 | 0.42% | 2.42% | 4.6分 |
| 106 | 昊海生科 | 0.06% | 2.02% | 4.9分 |
| 108 | 东星医疗 | -0.27% | 0.83% | 3.4分 |
| 110 | 冠昊生物 | -1.05% | -2.19% | 4.6分 |
| 112 | 大博医疗 | -1.35% | 2.60% | 4.8分 |
| 114 | 南卫股份 | -2.06% | 0.00% | 4.9分 |
| 116 | 联影医疗 | -3.09% | -0.73% | 4.5分 |
| 118 | 佰仁医疗 | -3.83% | -0.02% | 5.0分 |
| 120 | 迈瑞医疗 | -6.83% | -1.22% | 4.4分 |
| 122 | 万泰生物 | -8.59% | -1.90% | 4.0分 |
| 124 | 奥精医疗 | -9.31% | 0.22% | 3.9分 |
| 126 | 开立医疗 | -10.83% | 1.62% | 3.4分 |
| 128 | 力诺药包 | -12.46% | -3.99% | 3.5分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 安信证券 | 2012-09-04 | 增持 | 增持 |
| 长江证券 | 2012-09-02 | 增持 | - |
更多>>行业资讯
- 2012-09-13北京药监局通知全市停用8家企业中药饮片
- 2012-09-13澳洲股指周四收跌0.5% 医疗及消费股领跌
- 2012-09-13基层中医药服务能力将获提升
- 2012-09-132012中国医疗卫生产业发展论坛召开
- 2012-09-13医药行业：媒体称新版基药目录品种将扩至700个
- 2012-09-13陕西县级公立医院改革全面推开
- 2012-09-138月中山CPI 环比涨0.1%
- 2012-09-13中金公司：医药板块选股坚持“稳健业绩+成长空间预期
- 2012-09-13澳洲股指周四盘初跌0.5% 医疗及消费股领跌
- 2012-09-13感冒药“实名制”个人信息易“走光”？ 法国立法严管
基本面诊股
[ 截止日期：2025-03-31 ]公司经营
盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 99/250 ， 114/250。
[{"date":"2025-03-31","value":"0.26","vol":"1.15"},{"date":"2024-12-31","value":"2.47","vol":"0.53"},{"date":"2024-09-30","value":"1.94","vol":"4.75"},{"date":"2024-06-30","value":"1.45","vol":"3.53"},{"date":"2024-03-31","value":"0.82","vol":"1.63"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
0.26 | 2.47 | 1.94 | 1.45 | 0.82 |
| 行业(%) | 1.15 | 0.53 | 4.75 | 3.53 | 1.63 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"24.45","vol":"51.81"},{"date":"2024-12-31","value":"29.25","vol":"52.63"},{"date":"2024-09-30","value":"29.49","vol":"53.58"},{"date":"2024-06-30","value":"30.37","vol":"53.70"},{"date":"2024-03-31","value":"30.54","vol":"53.55"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
24.45 | 29.25 | 29.49 | 30.37 | 30.54 |
| 行业(%) | 51.81 | 52.63 | 53.58 | 53.70 | 53.55 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 59/250 ， 105/250。
[{"date":"2025-03-31","value":"2.58","vol":"-0.92"},{"date":"2024-12-31","value":"-11.19","vol":"0.64"},{"date":"2024-09-30","value":"-19.32","vol":"0.79"},{"date":"2024-06-30","value":"-22.36","vol":"0.16"},{"date":"2024-03-31","value":"-22.07","vol":"-1.36"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
2.58 | -11.19 | -19.32 | -22.36 | -22.07 |
| 行业(%) | -0.92 | 0.64 | 0.79 | 0.16 | -1.36 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"-68.87","vol":"-4.25"},{"date":"2024-12-31","value":"-67.66","vol":"-24.11"},{"date":"2024-09-30","value":"-73.82","vol":"-20.40"},{"date":"2024-06-30","value":"-73.25","vol":"8.56"},{"date":"2024-03-31","value":"-72.01","vol":"-16.42"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-68.87 | -67.66 | -73.82 | -73.25 | -72.01 |
| 行业(%) | -4.25 | -24.11 | -20.40 | 8.56 | -16.42 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 45/250 ， 102/250。
[{"date":"2025-03-31","value":"0.09","vol":"0.08"},{"date":"2024-12-31","value":"0.39","vol":"0.35"},{"date":"2024-09-30","value":"0.27","vol":"0.26"},{"date":"2024-06-30","value":"0.18","vol":"0.18"},{"date":"2024-03-31","value":"0.09","vol":"0.08"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.09 | 0.39 | 0.27 | 0.18 | 0.09 |
| 行业(次) | 0.08 | 0.35 | 0.26 | 0.18 | 0.08 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"0.26","vol":"0.55"},{"date":"2024-12-31","value":"1.03","vol":"2.33"},{"date":"2024-09-30","value":"0.69","vol":"1.67"},{"date":"2024-06-30","value":"0.45","vol":"1.13"},{"date":"2024-03-31","value":"0.22","vol":"0.54"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.26 | 1.03 | 0.69 | 0.45 | 0.22 |
| 行业(次) | 0.55 | 2.33 | 1.67 | 1.13 | 0.54 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-03-31","value":"-0.79","vol":"4.01"},{"date":"2024-12-31","value":"29.74","vol":"29.58"},{"date":"2024-09-30","value":"19.73","vol":"15.37"},{"date":"2024-06-30","value":"-0.86","vol":"13.04"},{"date":"2024-03-31","value":"18.23","vol":"2.55"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -0.79 | 29.74 | 19.73 | -0.86 | 18.23 |
| 行业 | 4.01 | 29.58 | 15.37 | 13.04 | 2.55 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"3.95","vol":"2.19"},{"date":"2024-09-30","value":"","vol":"0.01"},{"date":"2024-06-30","value":"4.76","vol":"2.31"},{"date":"2024-03-31","value":"","vol":"0.06"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 3.95 | - | 4.76 | - |
| 行业 | 0.00 | 2.19 | 0.01 | 2.31 | 0.06 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 4/250 ， 5/250。
[{"date":"2025-03-31","value":"2.07","vol":"5.89"},{"date":"2024-12-31","value":"1.99","vol":"5.34"},{"date":"2024-09-30","value":"2.03","vol":"5.97"},{"date":"2024-06-30","value":"2.03","vol":"5.95"},{"date":"2024-03-31","value":"1.93","vol":"6.44"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
2.07 | 1.99 | 2.03 | 2.03 | 1.93 |
| 行业 | 5.89 | 5.34 | 5.97 | 5.95 | 6.44 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"1.11","vol":"4.77"},{"date":"2024-12-31","value":"1.05","vol":"4.32"},{"date":"2024-09-30","value":"1.07","vol":"4.82"},{"date":"2024-06-30","value":"1.07","vol":"4.90"},{"date":"2024-03-31","value":"1.11","vol":"5.37"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
1.11 | 1.05 | 1.07 | 1.07 | 1.11 |
| 行业 | 4.77 | 4.32 | 4.82 | 4.90 | 5.37 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 9/250 ， 12/250。
[{"date":"2025-03-31","value":"38.09","vol":"21.24"},{"date":"2024-12-31","value":"38.43","vol":"21.92"},{"date":"2024-09-30","value":"38.44","vol":"21.09"},{"date":"2024-06-30","value":"37.83","vol":"21.07"},{"date":"2024-03-31","value":"37.09","vol":"20.36"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
38.09 | 38.43 | 38.44 | 37.83 | 37.09 |
| 行业(%) | 21.24 | 21.92 | 21.09 | 21.07 | 20.36 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"0.63","vol":"0.57"},{"date":"2024-12-31","value":"0.64","vol":"0.55"},{"date":"2024-09-30","value":"0.64","vol":"0.38"},{"date":"2024-06-30","value":"0.63","vol":"0.37"},{"date":"2024-03-31","value":"0.61","vol":"0.36"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.63 | 0.64 | 0.64 | 0.63 | 0.61 |
| 行业(%) | 0.57 | 0.55 | 0.38 | 0.37 | 0.36 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2025年的收益，请投资者后续关注。
[{"date":"2021","yellowRectValue":"8.28","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"8.47","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"6.00","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"1.94","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]